DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
DENTIUM Global manufacturer of premium dental implant systems and surgical tools for clinicians worldwide.	South Korea	145720
DENTSPLY SIRONA Inc. Global manufacturer of dental products, equipment, and digital solutions for professionals.	United States of America	XRAY
Deversify Health AB Developed mobile breathalyzers and apps for metabolic health for consumers, businesses & healthcare.	Sweden	DEV
Diagonal Bio AB Developing a platform for ultra-fast, PCR-accurate diagnostics of infectious diseases.	Sweden	DIABIO
Dignitana AB Develops a scalp cooling system for cancer patients to reduce hair loss during chemotherapy.	Sweden	DIGN
DIH HOLDING US, INC. Provides robotic and VR rehabilitation solutions for healthcare facilities worldwide.	United States of America	DHAI
DIO Corporation Global medical device company providing dental implants and innovative digital dentistry solutions.	South Korea	039840
DongBang Medical Co., Ltd. Manufactures devices for oriental medicine & aesthetics, including needles, threads, and fillers.	South Korea	240550
Draegerwerk AG & Co. KGaA Develops life-saving medical and safety technology for hospitals and industry.	Germany	DRW8
Edwards Lifesciences Corp Develops medical technology for structural heart disease, specializing in advanced heart valves.	United States of America	EW